Guangpui cited "outside the brain" to join in the development of Chinese herbal medicine

Recently, Dr. Fried Mullard, a Nobel laureate in physiology and medicine and a foreign academician of the Chinese Academy of Sciences, was appointed as the president of Guangzhou Pharmaceutical Research Institute of Guangyao Pharmaceutical Group and Zhong Nanshan, an academician of the Chinese Academy of Engineering, as honorary dean. The first phase of the capital pool reached 100 million yuan at the same time the Guangyao "Danan Drug" innovation fund was launched.

The joining of these world's top “outside brains” will start the journey of TCM to international again. This is also the first time that Chinese pharmaceutical companies have introduced the world's top new drug development team. According to reports, the innovation projects of the products of the subsidiary of GPHL will be packaged into the Guangzhou Pharmaceutical Research Institute, and the Muradian R&D team will conduct checks or direct research.